Fortress Biotech Pref Net Income
| FBIOP Preferred Stock | USD 11.11 0.20 1.77% |
As of the 13th of February 2026, Fortress Biotech shows the Mean Deviation of 2.74, downside deviation of 2.51, and Coefficient Of Variation of 559.23. Fortress Biotech Pref technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.
Analyzing historical trends in various income statement and balance sheet accounts from Fortress Biotech's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Fortress Biotech's valuation are summarized below:Fortress Biotech Pref does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Fortress |
Fortress Biotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Fortress Biotech's preferred stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Fortress Biotech.
| 11/15/2025 |
| 02/13/2026 |
If you would invest 0.00 in Fortress Biotech on November 15, 2025 and sell it all today you would earn a total of 0.00 from holding Fortress Biotech Pref or generate 0.0% return on investment in Fortress Biotech over 90 days. Fortress Biotech is related to or competes with Equillium, Coeptis Therapeutics, Century Therapeutics, Cue Biopharma, VTv Therapeutics, Senti Biosciences, and Genenta Science. Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology produc... More
Fortress Biotech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Fortress Biotech's preferred stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Fortress Biotech Pref upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.51 | |||
| Information Ratio | 0.1619 | |||
| Maximum Drawdown | 29.51 | |||
| Value At Risk | (4.32) | |||
| Potential Upside | 7.06 |
Fortress Biotech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Fortress Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Fortress Biotech's standard deviation. In reality, there are many statistical measures that can use Fortress Biotech historical prices to predict the future Fortress Biotech's volatility.| Risk Adjusted Performance | 0.1535 | |||
| Jensen Alpha | 0.8261 | |||
| Total Risk Alpha | 0.4274 | |||
| Sortino Ratio | 0.3075 | |||
| Treynor Ratio | 3.58 |
Fortress Biotech February 13, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1535 | |||
| Market Risk Adjusted Performance | 3.59 | |||
| Mean Deviation | 2.74 | |||
| Semi Deviation | 2.0 | |||
| Downside Deviation | 2.51 | |||
| Coefficient Of Variation | 559.23 | |||
| Standard Deviation | 4.77 | |||
| Variance | 22.75 | |||
| Information Ratio | 0.1619 | |||
| Jensen Alpha | 0.8261 | |||
| Total Risk Alpha | 0.4274 | |||
| Sortino Ratio | 0.3075 | |||
| Treynor Ratio | 3.58 | |||
| Maximum Drawdown | 29.51 | |||
| Value At Risk | (4.32) | |||
| Potential Upside | 7.06 | |||
| Downside Variance | 6.3 | |||
| Semi Variance | 4.01 | |||
| Expected Short fall | (3.50) | |||
| Skewness | 3.22 | |||
| Kurtosis | 13.9 |
Fortress Biotech Pref Backtested Returns
Fortress Biotech appears to be slightly risky, given 3 months investment horizon. Fortress Biotech Pref secures Sharpe Ratio (or Efficiency) of 0.2, which denotes the company had a 0.2 % return per unit of risk over the last 3 months. By reviewing Fortress Biotech's technical indicators, you can evaluate if the expected return of 0.95% is justified by implied risk. Please utilize Fortress Biotech's Coefficient Of Variation of 559.23, mean deviation of 2.74, and Downside Deviation of 2.51 to check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Fortress Biotech holds a performance score of 15. The firm shows a Beta (market volatility) of 0.24, which means not very significant fluctuations relative to the market. As returns on the market increase, Fortress Biotech's returns are expected to increase less than the market. However, during the bear market, the loss of holding Fortress Biotech is expected to be smaller as well. Please check Fortress Biotech's value at risk, as well as the relationship between the skewness and day median price , to make a quick decision on whether Fortress Biotech's price patterns will revert.
Auto-correlation | 0.54 |
Modest predictability
Fortress Biotech Pref has modest predictability. Overlapping area represents the amount of predictability between Fortress Biotech time series from 15th of November 2025 to 30th of December 2025 and 30th of December 2025 to 13th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Fortress Biotech Pref price movement. The serial correlation of 0.54 indicates that about 54.0% of current Fortress Biotech price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.54 | |
| Spearman Rank Test | 0.4 | |
| Residual Average | 0.0 | |
| Price Variance | 1.13 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Fortress Biotech Pref reported net income of (164.83 Million). This is 148.3% lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The net income for all United States preferred stocks is 128.87% higher than that of the company.
Fortress Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Fortress Biotech's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the preferred stocks which would be a good addition to a portfolio. Peer analysis of Fortress Biotech could also be used in its relative valuation, which is a method of valuing Fortress Biotech by comparing valuation metrics of similar companies.Fortress Biotech is currently under evaluation in net income category among its peers.
Fortress Fundamentals
| Return On Equity | -1.43 | ||||
| Return On Asset | -0.35 | ||||
| Profit Margin | (1.17) % | ||||
| Operating Margin | (2.63) % | ||||
| Current Valuation | 2.58 B | ||||
| Shares Outstanding | 56.68 M | ||||
| Shares Owned By Institutions | 1.80 % | ||||
| Number Of Shares Shorted | 245 | ||||
| Price To Sales | 1.36 X | ||||
| Revenue | 68.79 M | ||||
| Gross Profit | (85.66 M) | ||||
| EBITDA | (46.05 M) | ||||
| Net Income | (164.83 M) | ||||
| Cash And Equivalents | 248.77 M | ||||
| Cash Per Share | 2.31 X | ||||
| Total Debt | 46.56 M | ||||
| Debt To Equity | 0.81 % | ||||
| Current Ratio | 2.85 X | ||||
| Book Value Per Share | 0.57 X | ||||
| Cash Flow From Operations | (116.54 M) | ||||
| Short Ratio | 0.02 X | ||||
| Earnings Per Share | (0.86) X | ||||
| Number Of Employees | 173 | ||||
| Beta | 1.9 | ||||
| Market Capitalization | 107.79 M | ||||
| Total Asset | 396.5 M | ||||
| Z Score | 1.2 | ||||
| Annual Yield | 0.12 % | ||||
| Net Asset | 396.5 M |
About Fortress Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Fortress Biotech Pref's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Fortress Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Fortress Biotech Pref based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Fortress Biotech
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Fortress Biotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fortress Biotech will appreciate offsetting losses from the drop in the long position's value.Moving against Fortress Preferred Stock
| 0.83 | BROGF | BROGF | PairCorr |
| 0.77 | GLABF | Gemina Laboratories | PairCorr |
| 0.6 | ZTLLF | Zonetail | PairCorr |
| 0.49 | RVSN | Rail Vision | PairCorr |
The ability to find closely correlated positions to Fortress Biotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Fortress Biotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Fortress Biotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Fortress Biotech Pref to buy it.
The correlation of Fortress Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Fortress Biotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Fortress Biotech Pref moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Fortress Biotech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Fortress Preferred Stock Analysis
When running Fortress Biotech's price analysis, check to measure Fortress Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fortress Biotech is operating at the current time. Most of Fortress Biotech's value examination focuses on studying past and present price action to predict the probability of Fortress Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fortress Biotech's price. Additionally, you may evaluate how the addition of Fortress Biotech to your portfolios can decrease your overall portfolio volatility.